KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023
21 April 2023 - 9:01PM
Business Wire
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the
“Company”), a leading medical technology company focused on the
development, manufacturing, and commercialization of innovative and
easy-to-use subcutaneous drug delivery systems that improve quality
of life for patients, today announced that the Company will report
first quarter 2023 financial results on Thursday, May 4, 2023. KORU
Medical’s management will host a conference call and webcast at
4:30 p.m. ET that day to discuss the financial results and provide
a corporate update.
Conference Call and Webcast Details
The conference call can be accessed by dialing (800)-734-8507
for participants in the U.S. or Canada and (212)-231-2925 for
international callers, using conference ID: 22026692. A live and
archived webcast of the event can be accessed via the IR Calendar
on the News/Events page of the Investors section of KORU Medical’s
website at www.korumedical.com. The archived webcast will be
available for six months.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes
innovative and easy-to-use subcutaneous drug delivery systems that
improve quality of life for patients around the world. The FREEDOM
Syringe Infusion System currently includes the FREEDOM60® and
FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™
and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are
used for infusions administered in the home and alternate care
settings. For more information, please visit
www.korumedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230420005916/en/
Investor Contact: Greg Chodaczek 347-620-7010
investor@korumedical.com
KORU Medical Systems (NASDAQ:KRMD)
Historical Stock Chart
From Apr 2024 to May 2024
KORU Medical Systems (NASDAQ:KRMD)
Historical Stock Chart
From May 2023 to May 2024